Drug development
-
A first-of-a-kind daily oral blood thinner has been approved by the FDA to prevent clotting in people who have already experienced a stroke or what healthcare professionals call "mini" episodes. Secondary strokes are more dangerous than many realize.
-
Two trials involving more than 1,000 adults has all but guaranteed Eli Lilly's experimental drug retatrutide will be up for FDA approval for weight loss and potentially even knee osteoarthritis pain relief. It's a GLP-1-based drug, but not as we know it.